CO2022010604A2 - Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus - Google Patents

Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus

Info

Publication number
CO2022010604A2
CO2022010604A2 CONC2022/0010604A CO2022010604A CO2022010604A2 CO 2022010604 A2 CO2022010604 A2 CO 2022010604A2 CO 2022010604 A CO2022010604 A CO 2022010604A CO 2022010604 A2 CO2022010604 A2 CO 2022010604A2
Authority
CO
Colombia
Prior art keywords
coronavirus
surfactant
prevention
treatment
pharmaceutical composition
Prior art date
Application number
CONC2022/0010604A
Other languages
English (en)
Inventor
Rosado Rosa Maria Portillo
Original Assignee
Rosado Rosa Maria Portillo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosado Rosa Maria Portillo filed Critical Rosado Rosa Maria Portillo
Publication of CO2022010604A2 publication Critical patent/CO2022010604A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

a presente invención está referida a composiciones y formas farmacéuticas para el tratamiento y prevención del coronavirus, que contienen en su formulación colágeno no hidrolizado como tensoactivo con propiedades desgrasantes e ingredientes activos naturales en forma de polvos liofilizados de extractos acuosos de diente de león ( Taraxacum ojficinale ), anamu ( Petiveria alliacea), epazote ( Dysphania ambrosioides ), orégano ( Origanum vulgare ), anís estrellado ( Illicium verum ) conjuntamente con preservantes, así como los procedimientos de obtención y preparación asociados.
CONC2022/0010604A 2020-08-29 2022-07-28 Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus CO2022010604A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2020/058079 WO2022043738A1 (es) 2020-08-29 2020-08-29 Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus

Publications (1)

Publication Number Publication Date
CO2022010604A2 true CO2022010604A2 (es) 2022-10-11

Family

ID=80354728

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0010604A CO2022010604A2 (es) 2020-08-29 2022-07-28 Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus

Country Status (9)

Country Link
US (1) US20230057094A1 (es)
EP (2) EP4104851B1 (es)
CO (1) CO2022010604A2 (es)
CR (1) CR20220414A (es)
DO (1) DOP2022000178A (es)
EC (1) ECSP22066025A (es)
MX (1) MX2022009370A (es)
PE (1) PE20231359A1 (es)
WO (1) WO2022043738A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005037296A1 (ja) 2003-10-16 2006-12-28 東亞合成株式会社 抗コロナウイルス剤
CA2569080A1 (en) 2006-11-20 2008-05-20 Institut Pasteur Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus
CN105687226B (zh) 2016-01-27 2018-04-13 中国人民解放军疾病预防控制所 一种用于抑制冠状病毒感染的制剂
CN111281914A (zh) * 2020-02-16 2020-06-16 丁虹 一种治疗肺炎的中药组合物
CN111467414A (zh) * 2020-02-18 2020-07-31 上海蓝盎医学科技发展有限公司 一种治疗新冠状病毒的中药组合物及制备方法
CN111298049A (zh) * 2020-04-22 2020-06-19 南昌大学第一附属医院 一种治疗新型冠状病毒肺炎的中药组合物及其应用
CN111407859A (zh) * 2020-04-29 2020-07-14 北京天然风尚健康科技有限公司 一种具有抗菌抗病毒的功效的盔甲精油组合物制备方法和用途
CN111569010B (zh) * 2020-05-06 2021-08-20 石家庄市第五医院 一种中药组合物及其在制备治疗新冠肺炎的药物中的应用
CN111534877B (zh) * 2020-06-04 2021-01-15 广州市中诚新型材料科技有限公司 一种中药复方抗冠状病毒、流感病毒复合抗菌多功能纤维

Also Published As

Publication number Publication date
EP4104851A1 (en) 2022-12-21
EP4299132A2 (en) 2024-01-03
CR20220414A (es) 2022-09-15
PE20231359A1 (es) 2023-09-05
ECSP22066025A (es) 2022-09-30
WO2022043738A1 (es) 2022-03-03
EP4104851A4 (en) 2023-03-01
DOP2022000178A (es) 2022-11-15
EP4104851B1 (en) 2023-12-27
EP4104851C0 (en) 2023-12-27
US20230057094A1 (en) 2023-02-23
MX2022009370A (es) 2022-09-02
EP4299132A3 (en) 2024-02-21

Similar Documents

Publication Publication Date Title
DOP2017000137A (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo.
AR093181A1 (es) Formulacion con contenido de enzimas digestivas bajo estable
BR112019003410A2 (pt) composições e métodos para modulação da microflora gastrointestinal em um canino
CO2019006652A2 (es) Amidas aromáticas de ácidos carboxílicos como antagonistas del receptor de bradiquinina b1
PE20210106A1 (es) Composiciones de vacuna estables que comprenden inter alia un flavivirus recombinante vivo atenuado y proceso para la preparacion de las mismas
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
BR112018010945A2 (pt) formulações com degradação de polissorbato reduzida
CO2020005366A2 (es) Composición plaguicida que contiene tidiazurón y ácido poliglutámico
CO2022010604A2 (es) Composición farmacéutica que contiene un tensoactivo y extractos naturales de plantas para la prevención y tratamiento del coronavirus
AR109799A1 (es) Composición para el tratamiento del cabello
UY38982A (es) Composiciones farmacéuticas
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
DOP2023000084A (es) Formulación sólida
ECSP22092205A (es) Composición farmacéutica acuosa de levilimab y su uso
CL2022001779A1 (es) Composiciones que comprenden aminoácidos para la prevención y/o el tratamiento del cáncer
PH12018000227B1 (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
AR110984A1 (es) Composiciones que comprenden células recombinantes de bacillus y un insecticida
AR107195A1 (es) Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales
BR112021021841A2 (pt) Formulação de pó para administração intranasal, e método de fabricação da mesma
BR112017011276A2 (pt) mistura, mistura para o uso, composição, e composição para uso
UY37426A (es) Método para producir una composición farmacéuticamente estable presentada como una solución acuosa
UY36598A (es) Composición para el tratamiento de neuropatías y/o dolor neuropático
BR112018006648A2 (pt) formulações estáveis de fingolimode
CO2022011987A2 (es) Usos y composiciones a base de polifenoles para mejorar la biodisponibilidad oral del hidroxitirol
ECSP23086047A (es) Composición farmacéutica para prevenir o tratar la fibrosis